SCHEMBL6853714

SCHEMBL6853714

NC1C2CC3CC(C2)C(c2ccccc2C(=O)O)C1C3

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 2/20 0.41
GAA P10253 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
ALDH1A1 P00352 3/20 0.36
ALOX15 P16050 1/20 0.36
KDM4E B2RXH2 2/20 0.33
RBP4 P02753 2/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C19 P33261 1/20 0.33
G6PD P11413 1/20 0.33
CASP7 P55210 1/20 0.33
CASP6 P55212 1/20 0.33
MMP2 P08253 1/20 0.33
NAPRT Q6XQN6 2/20 0.33
CA12 O43570 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
HMGB1 P09429 1/20 0.33
HPGD P15428 1/20 0.33
CA4 P22748 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28223258 0.83 ALDH1A1 (0.45) CYP2C9GAAL3MBTL1ALDH1A1ALOX15
Hydrochloric Acid SCHEMBL2710119 0.82 CYP2C9 (0.44) CYP2C9GAAL3MBTL1ALDH1A1ALOX15
Benzoic Acid SCHEMBL29142624 0.78 TSHR (0.44) CYP2C9GAAL3MBTL1ALDH1A1ALOX15
SCHEMBL2365661 0.72 METAP2 (0.43) GAAALDH1A1KDM4EHPGDMAPT
SCHEMBL2710116 0.70 ALDH1A1 (0.41) GAAALDH1A1ALOX15KDM4EHPGD
SCHEMBL10011881 0.70 SCN9A (0.37) GAAALDH1A1KDM4EHPGDMAPT
SCHEMBL27943561 0.70 MMP2 (0.47) CYP2C9GAAL3MBTL1ALDH1A1ALOX15
SCHEMBL28731873 0.70 MAPT (0.47) CYP2C9GAAALDH1A1SMN1; SMN2MAPT
SCHEMBL1670564 0.70 CYP2C9 (0.51) CYP2C9ALDH1A1ALOX15KDM4ECYP3A4
SCHEMBL5834541 0.68 ALDH1A1 (0.41) GAAL3MBTL1ALDH1A1ALOX15KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1367046-A9 Disubstituted lavendustin A analogs and pharmaceutical compositions comprising the analogs THE UNITED STATES GOVERNMENT as represented by THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2004-05-12 EP disclosed
EP-1367046-A1 Disubstituted lavendustin A analogs and pharmaceutical compositions comprising the analogs THE UNITED STATES GOVERNMENT as represented by THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2003-12-03 EP disclosed
EP-1060160-A2 DISUBSTITUTED LAVENDUSTIN A ANALOGS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE ANALOGS THE UNITED STATES GOVERNMENT as represented by THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2000-12-20 EP disclosed
WO-1999043636-A2 DISUBSTITUTED LAVENDUSTIN A ANALOGS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE ANALOGS THE UNITED STATES OF AMERICA AS REPRESENTED BY THESECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 1999-09-02 WO disclosed